Diko : en:documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

en:documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

Catégories

Nom

Informations lexicales

Langue:anglais

Liens externes

›

umls:C3710401

Associations d'idées

[F]

›

363

en:documentation of patient survival and absence of stroke following cas

•

en:patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

•

en:functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan

•

en:all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

•

en:services performed by other qualified therapist in the hospice setting, each 15 minutes

•

en:patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

•

en:documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy

•

en:count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given

•

en:at least two different high-risk medications ordered

•

en:primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:aspirin prescribed at discharge

•

en:biologic immune response modifier prescribed

•

en:national committee for quality assurance - level 2 medical home

•

en:patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patient transferred directly from anesthetizing location to pacu

•

en:spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:no documentation of signed an opioid treatment agreement at least once during opioid therapy

•

en:patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

•

en:patients with a normal neurological examination

•

en:patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:antiretroviral thereapy not prescribed

•

en:advanced brain imaging (cta, ct, mra or mri) was not ordered

•

en:all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

•

en:attention functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patient survey score did not improve from baseline following treatment

•

en:chlamydia, gonorrhea, and syphilis not screened, reason not given

•

en:patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

•

en:motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:remission at six months not demonstrated by a six month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to five

•

en:intent for potential removal at time of placement

•

en:patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

•

en:patient required a return to the operating room within 90 days of surgery

•

en:patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder)

•

en:patient discharge to home no later than post-operative day #7

•

en:patient did not require a return to the operating room within 90 days of surgery

•

en:patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

•

en:non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:i intend to report the general surgery measures group

•

en:final reports for abdominal imaging studies with follow-up imaging recommended

•

en:final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study

•

en:final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

•

en:elective delivery or early induction performed

•

en:documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

•

en:documentation of patient discharged to home later than post-operative day 2 following cas

•

en:documentation of patient death following cea

•

en:documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)

•

en:asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

•

en:aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:antibiotic regimen prescribed

•

en:pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

•

en:intervention for presence of leak of endoluminal contents through an anastomosis not required

•

en:symptomatic aaas that required urgent/emergent (non-elective) repair

•

en:patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period

•

en:voice functional limitation, discharge status at discharge from therapy or to end reporting

•

en:total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

•

en:patient with minor blunt head trauma had an appropriate indication(s) for a head ct

•

en:admission to medicare care choice model program (mccm)

•

en:patient survey score improved from baseline following treatment

•

en:patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient not interviewed at least once during opioid therapy

•

en:patient is not eligible (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder neoplasia or otherwise to treat a bladder specific problem, patient death from other causes, etc.)

•

en:patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient has a valid reason for a head ct for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia)

•

en:patient sustained major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient did not sustain major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

•

en:other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

•

en:antiretroviral therapy prescribed

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

•

en:documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

•

en:documentation of patient stroke following cea

•

en:elective delivery or early induction not performed

•

en:i intend to report the sinusitis measures group

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)

•

en:voice functional limitation, current status at therapy episode outset and at reporting intervals

•

en:national committee for quality assurance - level 3 medical home

•

en:total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

•

en:patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

•

en:patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient interviewed at least once during opioid therapy

•

en:patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

•

en:beta-blocker therapy not prescribed, reason not given

•

en:final reports for abdominal imaging studies without a liver lesion < 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion < 1.0 cm noted

•

en:documentation of planned hybrid or staged procedure

•

en:documentation of patient with one or more complications within 90 days

•

en:documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)

•

en:clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)

•

en:all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

•

en:aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:antibiotic regimen prescribed within10 days after onset of symptoms

•

en:no return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:beta-blocker therapy prescribed or currently being taken

•

en:index date phq-score greater than 9 documented during the twelve month denominator identification period

•

en:clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason

•

en:specimen site other than anatomic cutaneous location

•

en:pneumococcal screening performed and documentation of vaccination received prior to discharge

•

en:patient presented within 24 hours of a minor blunt head trauma with a gcs score of 15 and had a head ct ordered for trauma by an emergency care provider

•

en:unplanned hospital readmission within 30 days of principal procedure

•

en:non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patient discontinued from hemodialysis or peritoneal dialysis

•

en:hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

•

en:final reports for ct or mri studies of the chest or neck or ultrasound of the neck without a thyroid nodule < 1.0 cm noted

•

en:final reports for abdominal imaging studies with follow-up imaging not recommended

•

en:documentation that patient is a current tobacco user

•

en:documentation of patient discharged to home no later than post operative day 2 following cas

•

en:documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta -lactam antibiotics)

•

en:ct studies performed reported to a radiation dose index registry with all necessary data elements

•

en:pneumococcal vaccination not administered prior to discharge, reason not specified

•

en:unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:tobacco assessment or tobacco cessation intervention not performed, reason not given

•

en:specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

•

en:sinusitis caused by, or presumed to be caused by, bacterial infection

•

en:services performed by volunteer in the hospice setting, each 15 minutes

•

en:screening performed and documentation that vaccination not indicated/patient refusal

•

en:radiation exposure indices, exposure time or number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given

•

en:all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

•

en:patient received one-time screening for hcv infection

•

en:patient has been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patients who were born in the years 1945-1965

•

en:patients who had a follow-up evaluation conducted at least every three months during opioid therapy

•

en:i intend to report the total knee replacement measures group

•

en:documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

•

en:count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study

•

en:all quality actions for the applicable measures in the general surgery measures group have been performed for this patient

•

en:amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

•

en:documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

•

en:documentation of medical reason(s) for not including documentation that follow up imaging is not needed (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))

•

en:patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)

•

en:unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)

•

en:preoperative assessment not documented, reason not given

•

en:patient treated with a beta-lactam antibiotic as definitive therapy

•

en:patient starting antiviral treatmentfor hepatitis c during the measurement period

•

en:patient received follow-up within 7 days from discharge

•

en:patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patients with 90 day mrs score of 0 to 2

•

en:rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:mapcp demonstration - state provided services

•

en:incidental thyroid nodule < 1.0 cm noted in report

•

en:door to puncture time of greater than 2 hours, no reason given

•

en:documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

•

en:documentation of patient without one or more complications and without mortality within 30 days

•

en:documentation of patient survival and absence of stroke following cea

•

en:documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

•

en:documentation of negative or managed positive tb screen with further evidence that tb is not active

•

en:major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:documentation that the patient is not on daily aspirin or anti-platelet regimen

•

en:patients who are currently statin therapy users or received an order (prescription) for statin therapy

•

en:mapcp demonstration - physician incentive pool

•

en:intraoperative cystoscopy performed to evaluate for lower tract injury

•

en:intervention for presence of leak of endoluminal contents through an anastomosis required

•

en:individual did not have a pdc of 0.8 or greater

•

en:history of injection drug use

•

en:currently a tobacco non-user

•

en:documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

•

en:documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

•

en:documentation of patient without one or more complications within 90 days

•

en:services performed by care coordinator in the hospice setting, each 15 minutes

•

en:ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

•

en:chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)

•

en:patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:antibiotic regimen not prescribed within 10 days after onset of symptoms

•

en:patient not offered assistance with end of life issues during the measurement period

•

en:any fasting or direct ldl-c laboratory test result = 190 mg/dl

•

en:shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given

•

en:services performed by chaplain in the hospice setting, each 15 minutes

•

en:prior thyroid disease diagnosis

•

en:post-partum screenings, evaluations and education performed

•

en:patient survey results not available

•

en:pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

•

en:p2y inhibitor not prescribed at discharge

•

en:order for anti-platelet agents or p2y12 antagonists was not documented, reason not otherwise specified

•

en:operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

•

en:documentation of viral load less than 200 copies/ml

•

en:documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family

•

en:documentation of medical reason(s) that follow-up imaging is not indicated (e.g., patient has a known malignancy that can metastasize, other medical reason(s)

•

en:documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:monitored anesthesia care (mac)

•

en:patient was referred to hospice care

•

en:patient starting antiviral treatment for hepatitis c during the measurement period

•

en:patient not discharged to home by post-operative day #7

•

en:p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

•

en:no photodocumentation of cecal landmarks to establish a complete examination

•

en:national committee for quality assurance - level 1 medical home

•

en:all necessary data elements not included, reason not given

•

en:i intend to report the cardiovascular prevention measures group

•

en:foot exam was not performed, reason not given

•

en:evaluation for wheelchair requiring face to face visit with physician

•

en:documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:documentation of an order for anti-platelet agents or p2y12 antagonists

•

en:ct studies performed not reported to a radiation dose index registry, reason not given

•

en:blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

•

en:at least two different high-risk medications not ordered

•

en:remission at twelve months not demonstrated by a twelve month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5

•

en:patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

•

en:documentation that patient is a current non-tobacco user

•

en:rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:no unplanned hospital readmission within 30 days of principal procedure

•

en:spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patient was not referred to hospice care, reason not given

•

en:patient received screening for hcv infection within the 12 month reporting period

•

en:patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

•

en:patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt, pe, mi, arrhythmia and stroke)

•

en:patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

•

en:statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

•

en:one-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given

•

en:patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

•

en:individual had a pdc of 0.8 or greater

•

en:filter removed within 3 months of placement

•

en:documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study)

•

en:documentation of patient with one or more complications or mortality within 30 days

•

en:clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)

•

en:all quality actions for the applicable measures in the aoe measures group have been performed for this patient

•

en:advanced brain imaging (cta, ct, mra or mri) was ordered

•

en:statin not prescribed at discharge

•

en:final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

•

en:pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:patient sustained ureter injury at the time of surgery or discovered subsequently up to 1 month post-surgery

•

en:patient did not receive follow-up on or within 7 days after discharge

•

en:patients with clinical ascvd diagnosis

•

en:patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

•

en:patients in whom mrs score could not be obtained at 90 day follow-up

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging recommended

•

en:order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

•

en:no documentation of negative or managed positive tb screen

•

en:hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

•

en:documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period

•

en:antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

•

en:post-partum screenings, evaluations and education not performed

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

•

en:blood pressure has a systolic value of < 140 and a diastolic value of < 90

•

en:preoperative assessment documented

•

en:patient not screened for unhealthy alcohol screening using a systematic screening method or patient did not receive brief counseling, reason not given

•

en:prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

•

en:screening for hcv infection not received within the 12 month reporting period, reason not given

•

en:remission at six months as demonstrated by a six month (+/-30 days) phq-9 score of less than five

•

en:psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

•

en:surgical site infection

•

en:patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

•

en:memory functional limitation, current status at therapy episode outset and at reporting intervals

•

en:elective surgical procedure

•

en:documentation that the patient is not on a statin medication

•

en:documentation of signed opioid treatment agreement at least once during opioid therapy

•

en:specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

•

en:motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

•

en:documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

•

en:documentation of active injection drug use

•

en:follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors

•

en:aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:incidental ct finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm

•

en:all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

•

en:patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

•

en:imaging study named according to standardized nomenclature

•

en:follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

•

en:documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

•

en:documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

•

en:pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:remission at twelve months as demonstrated by a twelve month (+/-30 days) phq-9 score of less than 5

•

en:warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

•

en:transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

•

en:the highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period

•

en:specimen site other than anatomic location of lung or classified as nsclc-nos

•

en:intraoperative cystoscopy not performed to evaluate for lower tract injury

•

en:primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:patients prescribed opiates for longer than six weeks

•

en:other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:i intend to report the multiple chronic conditions measures group

•

en:patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period

•

en:major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:patient received follow-up on the date of discharge or within 30 days after discharge

•

en:patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

•

en:patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

•

en:other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

•

en:one high-risk medication ordered

•

en:memory functional limitation, discharge status at discharge from therapy or to end reporting

•

en:documentation of patient survival in the hospital following endovascular aaa repair

•

en:i intend to report the optimizing patient exposure to ionizing radiation measures group

•

en:index date phq-9 score greater than 9 documented during the twelve month denominator identification period

•

en:documented reason for not assessing hepatitis b virus (hbv) status (e.g. patient not receiving a first course of anti-tnf therapy, patient declined) within one year prior to first course of anti-tnf therapy

•

en:documentation of patient stroke following cas

•

en:documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

•

en:photodocumentation of one or more cecal landmarks to establish a complete examination

•

en:documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

•

en:aspirin not prescribed at discharge

•

en:pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

•

en:spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

•

en:patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

•

en:spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:seen pre-operatively by anesthesiologist or proxy prior to the day of surgery

•

en:radiation exposure indices, exposure time or number of fluorographic images in final report for procedures using fluoroscopy, documented

•

en:patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient alive 3 months post procedure

•

en:patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

•

en:memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:mapcp demonstration - community health teams

•

en:history of receiving blood transfusions prior to 1992

•

en:documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

•

en:current cigarette smokers

•

en:attention functional limitation, current status at therapy episode outset and at reporting intervals

•

en:asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

•

en:patient offered assistance with end of life issues during the measurement period

•

en:influenza a (h1n1) and warfarin responsiveness testing

•

en:voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:transfer of care during an anesthetic or to the intensive care unit

•

en:statin prescribed at discharge

•

en:services performed by dietary counselor in the hospice setting, each 15 minutes

•

en:previously diagnosed or have an active diagnosis of clinical ascvd

•

en:patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

•

en:patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

•

en:patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

•

en:patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

•

en:patients with 90 day mrs score greater than 2

•

en:no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:no surgical site infection

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

•

en:documentation of patient death following cas

•

en:documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

•

en:attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:i intend to report the diabetic retinopathy measures group

•

en:documentation of patient death in the hospital following endovascular aaa repair

•

en:documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

•

en:specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

•

en:services performed by qualified pharmacist in the hospice setting, each 15 minutes

•

en:services performed by other counselor in the hospice setting, each 15 minutes

•

en:patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

•

en:patient taking tamsulosin hydrochloride

•

en:patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery, reason not given

•

en:patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

•

en:patient did not receive follow-up on the date of discharge or within 30 days after discharge

•

en:patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

•

en:p2y inhibitor prescribed at discharge

•

en:one high-risk medication not ordered

•

en:i intend to report the acute otitis externa (aoe) measures group

•

en:imaging study not named according to standardized nomenclature, reason not given

•

en:hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging not recommended

•

en:door to puncture time of less than 2 hours

•

en:documented re-assessment for the appropriateness of filter removal within 3 months of placement

•

intervention chirurgicale à froid

•

en:health care activity

◀

‹

362

en:patient with minor blunt head trauma had an appropriate indication(s) for a head ct

•

en:patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

•

en:chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)

•

intervention chirurgicale à froid

•

en:motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patient received one-time screening for hcv infection

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

•

en:patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:patient offered assistance with end of life issues during the measurement period

•

en:elective surgical procedure

•

en:ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:no surgical site infection

•

en:patient sustained ureter injury at the time of surgery or discovered subsequently up to 1 month post-surgery

•

en:advanced brain imaging (cta, ct, mra or mri) was not ordered

•

en:no unplanned hospital readmission within 30 days of principal procedure

•

en:patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

•

en:specimen site other than anatomic cutaneous location

•

en:rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:antiretroviral therapy prescribed

•

en:documentation of viral load less than 200 copies/ml

•

en:all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

•

en:asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

•

en:aspirin prescribed at discharge

•

en:all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

•

en:all quality actions for the applicable measures in the general surgery measures group have been performed for this patient

•

en:i intend to report the sinusitis measures group

•

en:surgical site infection

•

en:p2y inhibitor not prescribed at discharge

•

en:patient received follow-up on the date of discharge or within 30 days after discharge

•

en:patient discharge to home no later than post-operative day #7

•

en:elective delivery or early induction performed

•

en:beta-blocker therapy not prescribed, reason not given

•

en:biologic immune response modifier prescribed

•

en:documentation that the patient is not on daily aspirin or anti-platelet regimen

•

en:all necessary data elements not included, reason not given

•

en:aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

•

en:documented re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:chlamydia, gonorrhea, and syphilis not screened, reason not given

•

en:documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

•

en:all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

•

en:blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

•

en:antiretroviral thereapy not prescribed

•

en:aspirin not prescribed at discharge

•

en:at least two different high-risk medications not ordered

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

•

en:chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

•

en:antibiotic regimen prescribed

•

en:patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

•

en:patient not screened for unhealthy alcohol screening using a systematic screening method or patient did not receive brief counseling, reason not given

•

en:patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

•

en:patient did not receive follow-up on or within 7 days after discharge

•

en:attention functional limitation, discharge status at discharge from therapy or to end reporting

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

•

en:imaging study not named according to standardized nomenclature, reason not given

•

en:history of receiving blood transfusions prior to 1992

•

en:hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

•

en:hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

•

en:hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:final reports for abdominal imaging studies with follow-up imaging not recommended

•

en:functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan

•

en:final reports for ct or mri studies of the chest or neck or ultrasound of the neck without a thyroid nodule < 1.0 cm noted

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging not recommended

•

en:index date phq-score greater than 9 documented during the twelve month denominator identification period

•

en:filter removed within 3 months of placement

•

en:incidental thyroid nodule < 1.0 cm noted in report

•

en:major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:individual had a pdc of 0.8 or greater

•

en:memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:no return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:no documentation of signed an opioid treatment agreement at least once during opioid therapy

•

en:non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:national committee for quality assurance - level 2 medical home

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

•

en:memory functional limitation, current status at therapy episode outset and at reporting intervals

•

en:intervention for presence of leak of endoluminal contents through an anastomosis not required

•

en:mapcp demonstration - state provided services

•

en:mapcp demonstration - community health teams

•

en:dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

•

en:i intend to report the multiple chronic conditions measures group

•

en:i intend to report the diabetic retinopathy measures group

•

en:i intend to report the acute otitis externa (aoe) measures group

•

en:intraoperative cystoscopy not performed to evaluate for lower tract injury

•

en:elective delivery or early induction not performed

•

en:current cigarette smokers

•

en:door to puncture time of less than 2 hours

•

en:documentation of active injection drug use

•

en:documentation of medical reason(s) that follow-up imaging is not indicated (e.g., patient has a known malignancy that can metastasize, other medical reason(s)

•

en:documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

•

en:documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta -lactam antibiotics)

•

en:documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy

•

en:documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

•

en:one high-risk medication not ordered

•

en:ct studies performed reported to a radiation dose index registry with all necessary data elements

•

en:count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given

•

en:clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason

•

en:blood pressure has a systolic value of < 140 and a diastolic value of < 90

•

en:beta-blocker therapy prescribed or currently being taken

•

en:documentation of negative or managed positive tb screen with further evidence that tb is not active

•

en:documentation of patient death following cas

•

en:door to puncture time of greater than 2 hours, no reason given

•

en:documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

•

en:documentation that the patient is not on a statin medication

•

en:documentation that patient is a current tobacco user

•

en:documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study)

•

en:documentation of signed opioid treatment agreement at least once during opioid therapy

•

en:documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

•

en:documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

•

en:documentation of patient death in the hospital following endovascular aaa repair

•

en:documentation of patient with one or more complications or mortality within 30 days

•

en:documentation of patient without one or more complications and without mortality within 30 days

•

en:documentation of patient survival and absence of stroke following cea

•

en:documentation of patient stroke following cea

•

en:documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

•

en:documentation of patient discharged to home no later than post operative day 2 following cas

•

en:one-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given

•

en:patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient not interviewed at least once during opioid therapy

•

en:post-partum screenings, evaluations and education performed

•

en:remission at twelve months as demonstrated by a twelve month (+/-30 days) phq-9 score of less than 5

•

en:remission at six months as demonstrated by a six month (+/-30 days) phq-9 score of less than five

•

en:radiation exposure indices, exposure time or number of fluorographic images in final report for procedures using fluoroscopy, documented

•

en:prior thyroid disease diagnosis

•

en:preoperative assessment not documented, reason not given

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

•

en:seen pre-operatively by anesthesiologist or proxy prior to the day of surgery

•

en:pneumococcal screening performed and documentation of vaccination received prior to discharge

•

en:pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

•

en:patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

•

en:patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

•

en:patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

•

en:patient was not referred to hospice care, reason not given

•

en:screening for hcv infection not received within the 12 month reporting period, reason not given

•

en:services performed by chaplain in the hospice setting, each 15 minutes

•

en:patient taking tamsulosin hydrochloride

•

en:the highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period

•

en:warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

•

en:voice functional limitation, discharge status at discharge from therapy or to end reporting

•

en:unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:unplanned hospital readmission within 30 days of principal procedure

•

en:transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

•

en:total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

•

en:statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

•

en:services performed by other counselor in the hospice setting, each 15 minutes

•

en:spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

•

en:spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

•

en:specimen site other than anatomic location of lung or classified as nsclc-nos

•

en:services performed by qualified pharmacist in the hospice setting, each 15 minutes

•

en:patient treated with a beta-lactam antibiotic as definitive therapy

•

en:patient sustained major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:order for anti-platelet agents or p2y12 antagonists was not documented, reason not otherwise specified

•

en:patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patient alive 3 months post procedure

•

en:patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

•

en:patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

•

en:patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:patients with 90 day mrs score of 0 to 2

•

en:patient did not receive follow-up on the date of discharge or within 30 days after discharge

•

en:patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt, pe, mi, arrhythmia and stroke)

•

en:patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

•

en:patients prescribed opiates for longer than six weeks

•

en:pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:p2y inhibitor prescribed at discharge

•

en:other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

•

en:patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

•

en:patient survey score improved from baseline following treatment

•

en:at least two different high-risk medications ordered

•

en:patient survey results not available

•

en:patient starting antiviral treatmentfor hepatitis c during the measurement period

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

•

en:patient received screening for hcv infection within the 12 month reporting period

•

en:patient received follow-up within 7 days from discharge

•

en:patient presented within 24 hours of a minor blunt head trauma with a gcs score of 15 and had a head ct ordered for trauma by an emergency care provider

•

en:patient not offered assistance with end of life issues during the measurement period

•

en:patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient did not sustain major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient has a valid reason for a head ct for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia)

•

en:patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery, reason not given

•

en:patient discontinued from hemodialysis or peritoneal dialysis

•

en:patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

•

en:sinusitis caused by, or presumed to be caused by, bacterial infection

•

en:attention functional limitation, current status at therapy episode outset and at reporting intervals

•

en:i intend to report the cardiovascular prevention measures group

•

en:memory functional limitation, discharge status at discharge from therapy or to end reporting

•

en:mapcp demonstration - physician incentive pool

•

en:major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:i intend to report the total knee replacement measures group

•

en:i intend to report the optimizing patient exposure to ionizing radiation measures group

•

en:i intend to report the general surgery measures group

•

en:intraoperative cystoscopy performed to evaluate for lower tract injury

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

•

en:intervention for presence of leak of endoluminal contents through an anastomosis required

•

en:intent for potential removal at time of placement

•

en:individual did not have a pdc of 0.8 or greater

•

en:index date phq-9 score greater than 9 documented during the twelve month denominator identification period

•

en:incidental ct finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

•

en:imaging study named according to standardized nomenclature

•

en:monitored anesthesia care (mac)

•

en:motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

•

en:patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

•

en:patients who are currently statin therapy users or received an order (prescription) for statin therapy

•

en:patients in whom mrs score could not be obtained at 90 day follow-up

•

en:pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

•

en:operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

•

en:national committee for quality assurance - level 1 medical home

•

en:one high-risk medication ordered

•

en:one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

•

en:no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:no photodocumentation of cecal landmarks to establish a complete examination

•

en:no documentation of negative or managed positive tb screen

•

en:non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:national committee for quality assurance - level 3 medical home

•

en:history of injection drug use

•

en:patients who had a follow-up evaluation conducted at least every three months during opioid therapy

•

en:documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

•

en:documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:documentation of patient discharged to home later than post-operative day 2 following cas

•

en:documentation of patient death following cea

•

en:documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

•

en:documentation of patient survival and absence of stroke following cas

•

en:documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

•

en:documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period

•

en:documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:documentation of an order for anti-platelet agents or p2y12 antagonists

•

en:currently a tobacco non-user

•

en:ct studies performed not reported to a radiation dose index registry, reason not given

•

en:count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study

•

en:documentation of patient stroke following cas

•

en:documentation of patient survival in the hospital following endovascular aaa repair

•

en:foot exam was not performed, reason not given

•

en:evaluation for wheelchair requiring face to face visit with physician

•

en:follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging recommended

•

en:final reports for abdominal imaging studies with follow-up imaging recommended

•

en:final reports for abdominal imaging studies without a liver lesion < 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion < 1.0 cm noted

•

en:dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

•

en:documentation of patient without one or more complications within 90 days

•

en:documentation that patient is a current non-tobacco user

•

en:documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

•

en:documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

•

en:documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

•

en:documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

•

en:documentation of planned hybrid or staged procedure

•

en:documentation of patient with one or more complications within 90 days

•

en:patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

•

en:patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

•

en:asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

•

en:specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

•

en:symptomatic aaas that required urgent/emergent (non-elective) repair

•

en:statin prescribed at discharge

•

en:statin not prescribed at discharge

•

en:spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

•

en:spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

•

en:specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

•

en:total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

•

en:services performed by volunteer in the hospice setting, each 15 minutes

•

en:services performed by other qualified therapist in the hospice setting, each 15 minutes

•

en:services performed by dietary counselor in the hospice setting, each 15 minutes

•

en:services performed by care coordinator in the hospice setting, each 15 minutes

•

en:screening performed and documentation that vaccination not indicated/patient refusal

•

en:remission at twelve months not demonstrated by a twelve month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5

•

en:remission at six months not demonstrated by a six month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to five

•

en:tobacco assessment or tobacco cessation intervention not performed, reason not given

•

en:transfer of care during an anesthetic or to the intensive care unit

•

en:prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

•

en:all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

•

en:aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:any fasting or direct ldl-c laboratory test result = 190 mg/dl

•

en:antibiotic regimen prescribed within10 days after onset of symptoms

•

en:antibiotic regimen not prescribed within 10 days after onset of symptoms

•

en:amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

•

en:all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

•

en:all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

•

en:unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:all quality actions for the applicable measures in the aoe measures group have been performed for this patient

•

en:advanced brain imaging (cta, ct, mra or mri) was ordered

•

en:admission to medicare care choice model program (mccm)

•

en:influenza a (h1n1) and warfarin responsiveness testing

•

en:voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:voice functional limitation, current status at therapy episode outset and at reporting intervals

•

en:radiation exposure indices, exposure time or number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given

•

en:primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patients who were born in the years 1945-1965

•

en:patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder)

•

en:patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

•

en:patient has been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient interviewed at least once during opioid therapy

•

en:patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient did not require a return to the operating room within 90 days of surgery

•

en:patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

•

en:patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

•

en:patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

•

en:patients with clinical ascvd diagnosis

•

en:patients with a normal neurological examination

•

en:patients with 90 day mrs score greater than 2

•

en:patient not discharged to home by post-operative day #7

•

en:previously diagnosed or have an active diagnosis of clinical ascvd

•

en:patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

•

en:preoperative assessment documented

•

en:post-partum screenings, evaluations and education not performed

•

en:pneumococcal vaccination not administered prior to discharge, reason not specified

•

en:photodocumentation of one or more cecal landmarks to establish a complete examination

•

en:pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

•

en:pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

•

en:patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

•

en:patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

•

en:patient was referred to hospice care

•

en:patient transferred directly from anesthetizing location to pacu

•

en:patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient survey score did not improve from baseline following treatment

•

en:patient starting antiviral treatment for hepatitis c during the measurement period

•

en:patient required a return to the operating room within 90 days of surgery

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

◀

Génériques

[F] [H]

›

en:health care activity

• Mathieu Lafourcade • LIRMM (données libres en Creative Commons) •

• This page link : https://www.jeuxdemots.org/diko.php?gotermid=8128767 • caches: c1=8 c2=365 c3=363

....

♥

po

la

ti

le

as

ku

co

lo

to

ta

ta

xe

po

li

?!

!?

[Vider le cache]